Legend Biotech Capital Expenditures (CapEx) Growth & History (LEGN)
Legend Biotech's capital expenditures (capex) was $28.6M for fiscal 2025.
View full Legend Biotech company overviewLegend Biotech annual capital expenditures (capex) history
| Fiscal year | Period ended | Capital expenditures (CapEx) | Change | Growth |
|---|---|---|---|---|
| 2025 | 2025-12-31 | $28.6M | $14.5M | +102.84% |
| 2024 | 2024-12-31 | $14.1M | −$6.0M | −29.85% |
| 2023 | 2023-12-31 | $20.1M | −$827,000 | −3.95% |
| 2022 | 2022-12-31 | $20.9M | −$21.3M | −50.41% |
| 2021 | 2021-12-31 | $42.2M | $15.9M | +60.73% |
| 2020 | 2020-12-31 | $26.3M | −$519,000 | −1.94% |
| 2019 | 2019-12-31 | $26.8M | $5.8M | +27.75% |
| 2018 | 2018-12-31 | $21.0M | — | — |
Legend Biotech quarterly capital expenditures (capex)
| Fiscal quarter | Period ended | Capital expenditures (CapEx) | Change | YoY change |
|---|---|---|---|---|
| Q2 2026 | 2026-06-30 | $7.5M | −$1.7M | −18.69% |
| Q1 2026 | 2026-03-31 | $7.5M | $5.5M | +274.63% |
| Q4 2025 | 2025-12-31 | $12.4M | $10.0M | +421.24% |
| Q3 2025 | 2025-09-30 | $5.0M | $2.9M | +142.37% |
| Q2 2025 | 2025-06-30 | $9.2M | $5.8M | +169.79% |
| Q1 2025 | 2025-03-31 | $2.0M | −$4.2M | −67.93% |
| Q4 2024 | 2024-12-31 | $2.4M | −$2.0M | −45.59% |
| Q3 2024 | 2024-09-30 | $2.1M | −$3.3M | −61.60% |
| Q2 2024 | 2024-06-30 | $3.4M | −$2.7M | −43.84% |
| Q1 2024 | 2024-03-31 | $6.2M | $2.0M | +46.07% |
| Q4 2023 | 2023-12-31 | $4.4M | — | — |
| Q3 2023 | 2023-09-30 | $5.4M | $2.8M | +108.57% |
| Q2 2023 | 2023-06-30 | $6.1M | — | — |
| Q1 2023 | 2023-03-31 | $4.3M | — | — |
| Q3 2022 | 2022-09-30 | $2.6M | — | — |
Legend Biotech capital expenditures (capex) trends
Over the last five fiscal years, Legend Biotech's capital expenditures (capex) increased from $26.3M to $28.6M, a change of $2.3M. The latest reported quarter, Q2 2026, shows $7.5M.
What capital expenditures (CapEx) mean
Capital expenditures, commonly called CapEx, are cash investments in long-lived assets such as property, plants, equipment, infrastructure, and productive software. CapEx can support future growth or maintain existing operations, but it reduces current-period free cash flow.
SEC-reported capital expenditures
TickerStat standardizes cash payments for property, plant, equipment, and other productive assets reported in company SEC filings. When a filer reports separate qualifying CapEx components instead of a total, those components are combined for the same fiscal period. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Legend Biotech source filings ↗